Chennai: 'Gleneagles Global Health City' Hospital In Collaboration With Cipla On Friday Announced The Launch Of Roche&Rsquo;S Antibody Drug Cocktail For Early Covid-19 Treatment In Chennai. The Anti-Body Cocktail Will Also Be Available At Gleneagles Global&Rsquo;S Bengaluru And Hyderabad Hospitals.Swiss Pharma Company, Roche'S Product Is A Cocktail Of Two Monoclonal Antibodies (Tailor-Made Antibodies Created In Laboratories) Casirivimab And Imdevimab.The Drug Has Fda Emergency Use Approval For Treatment Of Mild To Moderate Covid-19 Patients With Comorbidities Who Are At A High Risk Of Getting Severely Ill. India'S Central Drugs Standards Control Organisation (Cdsco) Has Also Approved The Drug Based On The Data Filed With The Us Regulators As Well As Considering The Scientific Opinion Of The European Regulatory Panel.The Monoclonal Antibodies Can Attach To Parts Of The Virus, And These Antibodies Could Help The Immune System Recognize And Respond More Effectively To The Virus. People Who Are Likely To Get Very Sick From Covid-19 Are Recommended To Receive This Treatment," Stated The Release.High Risk Patients Above The Age Of 12 Who Have Comorbidities And Have Positive Pcr Or Rat Test Results Are Eligible To Take The Drug.The Drug Has Only To Be Administered To The Patients Within Five Days From The Onset Of Symptoms, Within Three Days From Pcr Report, Before Requiring Hospitalisation And Oxygen Support And With Their Willingness And Consent For The Treatment."The Drug Acts On High-Risk Patients Before Their Condition Worsens, Reducing The Risk Of Hospitalisation And Fatality By 70 Per Cent And Shortening The Duration Of Symptoms," Added The Release.Dr Subramanian Swaminathan, Director Of Infectious Diseases, Gleneagles Global Health City, Chennai Said, &Ldquo;With Almost 1.86 Lakh New Number Of Cases In The Country Today It Is The Need Of The Hour To Curb The Spread Of The Virus And To Provide Another Option To Help Keep High-Risk Patients With Comorbidities Out Of The Hospital. Studies Indicate That The Drug Can Significantly Shorten The Duration Of Covid-19 Symptoms.&Rdquo; Further Adding To It, Dr Alok Khullar, Ceo - Gleneagles Global Health City, Chennai, Said, &Ldquo;The Antibody-Drug Cocktail Is Currently The Only Available Intervention For Early-Stage Treatment Of Covid-19 Patients That Reduces Severity, Need For Hospitalization As Well As Possibly Prevailing Covid-19 Crisis By Reducing Fatality Rates. Making It Available At Gghc Was A Decision Taken By Our Management And Medical Experts After Analysing And Evaluating The Data That Is Available. With The Prompt Approvals From Cdsco, Thousands Of Patients Would Enjoy The Benefit Of A Quick Recovery.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!